Globus Medical Inc
GMED· NYSE
GMEDGlobus Medical Inc
Released Aug 6, 2024, after the close
10-Q filed Aug 6, 2024, 37 days after period end · 0001562762-24-000199
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $629.69M | $291.62M | $263.65M | $251.02M |
| Net Income | $31.76M | $57.71M | $54.59M | $41.55M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $0.23 |
| $0.57 |
| $0.53 |
| $0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
